| Presentor(s) |
D.J. van Veldhuizen, Groningen (NL) |
| Episode |
44 |
| Year |
2008 |
| Duration |
14:50 |
Shownotes "BNP is a widely used biomarker for heart failure but is dependent on age, hemoglobin and renal function. Indexing BNP for these parameters therefore seems necessary. Specificity of BNP is not ideal as some CHF patients still have low BNP. Whether lowering BNP improves patient's outcome is still unclear. BNP levels do also not predict the effectiveness of CRT. Device diagnostics have the potential of predicting hospitalizations for heart failure and managing these patients more effectively. Combining biomarkers with device diagnostics will become important in the management of patients with heart failure."
